Vontobel Holding
PASG icon

Vontobel Holding’s Passage Bio PASG Stock Holding History

Vontobel Holding’s Portfolio PASG Stock Details PASG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-4,000
Closed -$76.6K – 1134
2023
Q1 		$76.6K Buy
4,000
+2,250
+129% +$61K ﹤0.01% 1033
2022
Q4 		$48.3K Hold
1,750
– – ﹤0.01% 1065
2022
Q3 		$44K Hold
1,750
– – ﹤0.01% 1012
2022
Q2 		$83K Hold
1,750
– – ﹤0.01% 986
2022
Q1 		$109K Hold
1,750
– – ﹤0.01% 1032
2021
Q4 		$222K Buy
1,750
+250
+17% +$40.8K ﹤0.01% 981
2021
Q3 		$299K Hold
1,500
– – ﹤0.01% 941
2021
Q2 		$397K Hold
1,500
– – ﹤0.01% 831
2021
Q1 		$524K Buy
1,500
+500
+50% +$213K ﹤0.01% 661
2020
Q4 		$511K Buy
+1,000
New +$400K ﹤0.01% 651

Other funds holding PASG

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vontobel Holding's PASG Position: Q2 2023 in Review

Vontobel Holding sold out of Passage Bio (PASG) in Q2 2023, closing a stake of 4,000 shares — an estimated $76.6K sold.

Vontobel Holding first reported a position in PASG in Q4 2020 and held it in 10 quarters. The position peaked at $524K in Q1 2021. 54 funds tracked by Wall St. Rank hold PASG as of Q2 2023.

  • Vontobel Holding reported no remaining Passage Bio position as of Q2 2023 after selling out during the quarter.
  • Vontobel Holding sold 4,000 Passage Bio shares in Q2 2023, an estimated $76.6K.
  • Vontobel Holding first reported a position in Passage Bio in Q4 2020 and held it in 10 quarters.
  • Vontobel Holding's Passage Bio position peaked at $524K in Q1 2021.
  • 54 funds tracked by Wall St. Rank held Passage Bio as of Q2 2023.

Based on Vontobel Holding's 13F filing for Q2 2023, filed 24 Jul 2023.